MSBASE INTRODUCED TO NEW ZEALAND
June 26, 2018Allowing people with MS in to participate in international researchread more
Allowing people with MS in to participate in international researchread more
A promising study originally funded by an MS Research Australia Incubator Grant has found some molecules in the blood which may help diagnose MS. This work could be used to develop a…read more
The final day of what has been an incredibly busy but enormously inspiring conference – packed with great science, but also productive meetings building international collaborations.read more
Another diverse and jam-packed day! The breadth of the sessions and topics, the sense of energy, as well as the sheer size of this conference, really demonstrates how no stone…read more
Although the conference was well underway yesterday, today began with the official Opening and Welcome led by the Presidents of ECTRIMS and ACTRIMS, Professors David Miller and Jack Antel and…read more
It’s been quite a first day at the biggest MS conference in the world. The European Committee for Treatment and Research in MS and the Americas Committee for Treatment and…read more
Magnetic resonance Imaging (MRI), is something people with MS are very familiar with, it creates diagnostic pictures of the brain and spinal cord by using magnetic fields rather than x-ray…read more
There is a great deal of scientific and community interest in the role that stem cells might play in treating MS. Stem cell therapy is a treatment that uses or targets stem…read more
A small clinical trial of clemastine fumarate, a common, over-the-counter allergy medication, has been conducted in people with MS and has shown exciting evidence for myelin repair.read more
A significant portion of people with MS will experience falls, with research showing that in the previous six months up to 60% of people with MS will have fallen. A…read more
In MS the immune system attacks the central nervous system (the brain and spinal cord), stripping the protective myelin layer off individual neurons. Removing this protective layer not only hampers the ability…read more
Last week we saw the media pick up on a study just published about a potential link between head injuries and the risk of developing MS.read more
While there has been great progress in the development of effective treatments for relapsing remitting MS over the last 15 years, there has not been the same advances in treatments…read more
Cladribine, an oral treatment for relapsing remitting MS, previously approved in Australia, but subsequently withdrawn, is making a comeback.read more
There is a growing interest in the role of gut bacteria in inflammatory disorders such as MS. Gut bacteria (also referred to as our microbiome) play a crucial role in…read more
MS is often diagnosed in younger adulthood, when a person’s career is starting to develop and take off. Some people with MS have reported leaving the workforce or reducing their…read more
Australian researchers discover a gene which might influence MS relapse rates. Our genes influence everything about us, including the way we look, the way we act and of course they…read more
MS Research Australia has been reporting on every step that Ocrevus a new MS medication, has taken on its journey to become the first ever approved treatment for progressive MS…read more
Type the words “alternative therapies” and “multiple sclerosis” into google and thousands of articles are listed. It is likely that many people with MS have done this, as just over…read more
One of the perennial questions of MS research is, what is it that triggers the attack on the nervous system in the first place?read more